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Abstract 
Purpose: To investigate the effect of Yushen zhuyun decoction (YSZYF) on rats with diminished 
ovarian reserve (DOR). 
Methods: High-performance liquid chromatography (HPLC) was used to determine the major 
phytochemical constituents of YSZYF. Rats with DOR (DOR rats) were prepared by administration of 
tripterygium glycosides (TWP) orally (50 mg/kg) for 15 days. Thereafter, DOR rats were treated orally 
with YSZYF (300, 600 and 900 mg/kg). After 15 days’ treatment, ovary index was calculated and blood 
was obtained to determine serum levels of follicle-stimulating hormone (FSH), estradiol (E2), 
progesterone (P), testosterone (T), inhibin (INH) and anti-mullerian hormone (AMH) by 
radioimmunoassay and enzyme-linked immunosorbent assay (ELISA). In addition, the ovary was 
subjected to histopathological examinations.  
Results: Phytochemical investigation indicated that the major constituents of YSZYF are acteoside, 
loganin, lcariin and echinacoside. Compared to the control rats, YSZYF treatment enhanced the ovary 
index of DOR rat (p < 0.05); furthermore, YSZYF treatment also enhanced the number of follicles and 
corpus luteum, as well as alleviated inflammatory reaction in ovary tissues. Additionally, the serum 
levels of FSH and T were elevated by treatment of YSZYF (p < 0.01), whereas E2, INHB and AMH 
concentrations decreased (p < 0.01), compared to control rats.  
Conclusion: The findings indicate that YSZYF improves ovarian reserve of DOR rats, and thus has a 
potential for treating infertility.   
 
Keywords: Yushen zhuyun decoction, Diminished ovarian reserve, Infertility, Acteoside, Loganin, 
Lcariin, Echinacoside 
 
Tropical Journal  of Pharmaceutical Research is indexed by Science Citation Index (SciSearch), Scopus, 
International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African 
Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals 




Infertility is a worldwide reproductive health 
problem which could destroy the happiness in 
individuals and families [1,2]. Currently, it is 
reported that in vitro fertilization and embryo 
transfer (IVF-ET) could improve the pregnancy 
rate of husband and wife with infertility; however, 
the pregnancy rate is still less than 50% [3,4]. 
The reasons for infertility are complex, and the 
diminished ovarian reserve (DOR) is one of the 
most important reasons [5,6]. Ovarian reserve 
(OR) is defined as the number and quality of 
remaining oocytes in ovarian cortex, reflects the 
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fertility potency and reproductive endocrine 
function of women [7,8]. DOR indicates that the 
follicle can be recruited and the egg productive 
abilities of ovaries are diminished, leading to a 
decrease in a woman’s fertility [7,9].  
 
Traditional Chinese Medicine (TCM) has been 
used in China for treating various complicated 
diseases, and are also considered a potential 
approach for solving infertility [10,11]. Yushen 
zhuyun decoction (YSZYF, Table 1) is an 
effective clinical TCM for treating infertility in 
China [12,13]. However, so far, experimental 
research on YSZYF regarding its detail 
phytochemical and pharmacological activity is 
still lacking. Consequently, this study was aimed 
to investigate the major chemical composition of 
YSZYF, and explore its possible pharmacological 




Chemicals and reagents 
 
Tripterygium glycosides (TWP) tablets (10 
mg/tablet) were purchased from Jiangsu 
MEITONG Pharmaceutical Co. Ltd. (Taizhou, 
China). Estradiol valerate (EV) tablets (1 
mg/tablet) were purchased from the Delpharm 
Lille S.A.S (France); follicle-stimulating hormone 
(FSH), estradiol (E2), progesterone (P) and 
testosterone (T) radioimmunoassay kits were the 
products of the Beijing North Institute of Biotech. 
(Beijing, China); Inhibin (INH) and anti-mullerian 
hormone (AMH) ELISA kits were purchased from 





Experimental groups consisted of Sprague 
Dawley (SD) rats (250 - 280 g) which were 
supplied by the Shanghai SLRC Lab. Animal Co. 
(Shanghai, China). The experimental protocols 
obey the international animal experimental 
guideline [14] and were approved by the Animal 
Care and Use Committee of Shanghai General 
Hospital (no. 15030001). 
 
Preparation of water extracts of YSZYF 
 
For clinical use, YSZYF is traditionally prepared 
by decocting with water directly. Thus, all the 
crude herbal drugs of YSZYF (Table 1) were 
powdered and then decocted thrice with 10 times 
its weight of water. The mixture was filtered and 
the clear supernatant was concentrated in 
vacuum at 50 °C; the dry yield of YSZYF was 
12.58 %. 
 
Phytochemical investigation of YSZYF by 
HPLC 
 
The water extract of YSZYF was dissolved in 
methanol for preparing and testing samples for 
HPLC assay. HPLC assay was carried out on an 
Agilent Technologies 1200 system (USA) with a 
ZORBA× SB-C18 column (250 × 4.6 mm, 5 µm). 
The mobile phase contains acetonitrile (A) and 
water (B) in gradient elution at a flow rate of 0.8 
mL/min, 0 min A:B =10:90, after 30 min A:B 
100:0. The detection wavelength was 240 nm of 




In the present study, a total of 60 SD rats were 
divided into 6 groups (n=10): 1) normal rats, 2) 
DOR model rats, 3) positive drug treated DOR 
rats, and 4-6) YSZYF treated DOR rats (300, 600 
and 900 mg/kg). DOR model rats were prepared 
by oral administration of TWP at the dose of 50 
mg/kg for 15 days. Also, for the drugs treated 
DOR rats, EV (0.21 mg/kg) and YSZYF (300, 
600 and 900 mg/kg) were also administered 
orally for 15 days. Furthermore, the EV and 
YSZYF were dissolved in water for 
administration. After 15 days’ treatment, blood 
samples were collected from the abdominal aorta 
blood using vacuum blood collection tube under 
anesthesia (pentobarbital sodium, 40 mg/kg, 
i.p.). Then, rats were sacrificed with decapitation, 
and the ovary was separated. The weight of 





Ovary tissues were fixed with 10 % formalin, and 
embedded in paraffin. The ovarian tissues were 
sectioned to 5 μm thickness, and stained with 
hematoxylin and eosin (H&E). The 
histopathological changes in ovarian tissues 
were examined using a microscope (Olympus, 
Japan). 
 
Determination of serum levels of FSH, E2, T, 
P, INH and AMH 
 
The blood samples were centrifuged (3000 rpm, 
10 min) to separate serum samples, and stored 
at -20 °C until analysis. The serum levels of FSH, 
E2, T and P were determined by 
radioimmunoassay according to the instructions 
of radioimmunoassay kits. In addition, the serum 
levels of INH and AMH were determined by 
ELISA method following the instructions of ELISA 
kits.  
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Table 1: Composition of YSZYF 
 
Name Amount (g)  Name Amount (g) 
Poria Locos 12  Rehmannia Glutinosa 10 
Fructus Corni 10  Tortoise Plastron 10 
Cornu Cervi Degelatinatum 10  Epimedium Herb 10 




Figure 1: HPLC chromatogram of YSZYF. (A) HPLC spectrum of standard references compounds, 1-
4 represented acteoside, loganin, lcariin and echinacoside, respectively; (B) HPLC spectrum of 
sample; The HPLC analysis was performed on an ZORBA× SB-C18 column (250 × 4.6 mm, 5 µm). 
The mobile phase was composed of acetonitrile (A)-water(B) in gradient elution at a flow rate of 
0.8ml/min, 0 min A:B = 10:90, after 30 min A:B 100:0. The detection wavelength was 240 nm of and 




Data were presented as mean ± SD and 
evaluated with one-way analysis of variance 
(ANOVA) analysis, and the differences were 




Phytochemical profile of YSZYF 
 
The base peaks and UV chromatograms of the 
YSZYF sample by HPLC assay were presented 
in Figure 1. According to the results, four major 
phytochemical components, including acteoside, 
loganin, lcariin and echinacoside were detected 
by comparing their retention times, UV spectra 




Ovarian index data are shown in Figure 2. After 
administration of TWP (50 mg/kg) for 15 days, 
the ovarian indexes of DOR model rats were 
decreased obviously (p < 0.01), compared with 
the normal rats, indicating that the ovarian 
weights of DOR model rats decreased, 
compared with normal rats. Interestingly, similar 
to the positive drug (EV, 0.21 mg/kg), YSZYF 
administration at doses of 300, 600 and 900 
mg/kg significantly increased ovarian indexes of 
DOR rats (p < 0.05, p < 0.01, p < 0.01), 
compared with DOR model rats. 
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Figure 2: Ovarian index. Estradiol valerate was used as the positive drug, and the dose was 0.21 
mg/kg. All the tested drugs were administered orally. For normal mice, normal saline was 





As can be seen from Figure 3, the ovarian tissue 
section of normal rats showed that ovarian 
structure and no. of follicles are normal, while 
primordial follicles, primary follicles, secondary 
follicles and mature follicles are visible. Follicular 
fluid content and corpus luteum are normal, and 
no inflammatory response and fibrosis were 
observed. Furthermore, ovarian tissue sections 
of DOR model rats indicate inflammatory 
reactions, some tissues were atrophied, no. of 
follicles and corpus luteum decreased obviously, 
and structure and cell arrangement is irregular. 
Importantly, after treatment with EV and YSZYF, 
the ovarian tissue sections of DOR rats showed 
a significant improvement. The no. of follicles in 
various stages as well as the no. of corpus 
luteum increased, while cell arrangement and 





Figure 3: Histopathological characteristics of ovaries (× 40). Estradiol valerate (0.21 mg/kg) was used 
as the positive control. All the tested drugs were administered orally. For normal mice, normal saline 
was administered orally 
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Serum levels of FSH, E2, T and P  
 
The serum levels of FSH, E2, T and P data are 
presented in Figure 4. After administration with 
TWP (50 mg/kg) for 15 days, serum levels of 
FSH and T significantly elevated (p < 0.01), 
compared with the normal rats. However, YSZYF 
treatment at doses of 300, 600 and 900 mg/kg 
dose-dependently decreased serum levels of 
FSH and T (p < 0.01), compared with DOR 
model rats. Compared with normal rats, contents 
of E2 decreased after treating TWP (50 mg/kg) 
for 15 days (p < 0.01). In contrast, YSZYF 
treatment (300, 600 and 900 mg/kg) dose-
dependently increased E2 contents in serum (p < 
0.01), compared with DOR model rats. Besides, 
no obvious change in serum level of P (p > 0.05) 
occurred. 
 
Effect of decoction on serum levels of INH 
and AMH  
 
Serum levels of INH and AMH are shown in 
Figure 5. Compared with normal rats, serum 
levels of INH and AMH in DOR control rats 
significantly decreased (p < 0.01). On the other, 
serum levels of INH and AMH increased dose-
dependently following treatment with YSZYF at 
doses of 300, 600 and 900 mg/kg (p < 0.01), 
compared with DOR control rats. 
 
 
Figure 4: Results of FSH, E2, T and P determination in serum. Estradiol valerate was used as the 
positive drug, and the dose was 0.21 mg/kg. All the test drugs were administered orally. For normal 
mice, normal saline was administered orally. Data are expressed as mean ± SD (n = 10), **p < 0.01, 




Figure 5: Serum levels of INH and AMH. Estradiol valerate was used as the positive drug (0.21 
mg/kg). For normal mice, normal saline was administered orally. Data are expressed as mean ± SD 
(n=10); **p < 0.01, compared with model mice. INH = inhibin, AMH = anti mullerian hormone 
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The present work reported the effects of Yushen 
zhuyun decoction (YSZYF) on rats with 
diminished ovarian reserve (DOR), and revealed 
for the first time that YSZYF possesses 
significant ameliorative effects on DOR rats.  
 
Ovarian reserve (OR) reveals the effect of the 
state of the ovary on egg production, and thus 
reflects the degree of fertility of women [1,2]. 
Clinically, DOR commonly reflects changes in 
menstrual cycle, infertility and abortion, and 
could decrease the success rate of in vitro 
fertilization (IVF), leading to ovarian atrophy [15]. 
Consequently, improving DOR is important for 
enhancing fertility of women. TWP-induced DOR 
rat model is a reliable experimental animal model 
to evaluate the effect of a candidate fertility drug 
[16]. For control rats, ovarian index and serum 
levels of E2, INHB and AMH decreased, whereas 
the serum level of FSH increased compared to 
normal rats, indicating that DOR rats were 
established successfully.  
 
The present results demonstrate that after 
treatment with YSZYF, ovarian index was 
increased, suggesting that YSZYF could be used 
to improve the ovarian atrophy of women with 
DOR. Furthermore, our study also revealed that 
treatment with YSZYF could increase the 
numbers of follicles in various stages and corpus 
luteums in ovary of DOR rats, indicating YSZYF 
can be used to improve the ovarian reserve of 
women with DOR. Currently, it is reported that 
follicular development in normal menstrual cycle 
dependent on the stimulation of gonadotropins, 
such as FSH, T, E2 and P, etc [17].  
 
INHB can be considered a marker of ovarian 
reserve, since a decrease in INHB level 
frequently reflects follicular decline and ovarian 
senescence [18,19]. AMH, released by follicular 
cells, is a suitable index for early ovarian reserve, 
and can be used to predict pregnancy outcome 
[20,21]. In addition, AMH is an indicator of follicle 
production, and usually decreases gradually with 
age [21]. The results indicate that serum levels of 
INHB and AMH increased significantly, while 
FSH decreased. In addition, these results 
indicate that YSZYF increases the follicular 




The findings of this study demonstrate that 
YSZYF is effective in improving ovarian 
reservation in experimental DOR rats, and thus 
can enhance follicular development and follicle 
development. Thus, the results suggest that 
YSZYF possesses some potentials for treating 
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